Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

1.1K
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
1.1K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

1.5K
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
1.5K
Stimulants01:29

Stimulants

1.4K
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
1.4K
Adrenergic Agonists: Indirect-Acting Agents01:25

Adrenergic Agonists: Indirect-Acting Agents

2.8K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.8K
Adrenergic Agonists: Mixed-Action Agents01:28

Adrenergic Agonists: Mixed-Action Agents

1.7K
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
1.7K
An Overview of Psychoactive Drugs01:28

An Overview of Psychoactive Drugs

866
Psychoactive drugs impact brain function, influencing perception, mood, consciousness, cognition, and behavior. These substances are grouped based on their effects and the mechanisms by which they act.
Stimulants such as cocaine, amphetamines, and nicotine enhance brain activity, leading to increased alertness, attention, and energy. These drugs typically raise heart rate, blood pressure, and body temperature. While they can induce feelings of euphoria, their misuse can result in severe health...
866

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The national burden from O'nyong'nyong and chikungunya viruses in Cameroon.

medRxiv : the preprint server for health sciences·2026
Same author

Disparities in Diagnostic Yield of Genetic Testing in Children and Adolescents With Vascular Malformations and/or Overgrowth: A Single Site Experience.

American journal of medical genetics. Part A·2026
Same author

An integrative approach for studying immunological variation in an aging population - The Milieu Intérieur follow-up study.

Nature communications·2026
Same author

Understanding <i>Plasmodium vivax</i> recurrent infections using an amplicon deep sequencing assay, identity-by-descent and model-based classification.

iScience·2026
Same author

Host-cell dependent epigenetic profiles associated with survival outcomes in T. gondii infection.

Epigenetics & chromatin·2026
Same author

Parasite and gametocyte dynamics and infectivity to mosquitoes during recurrent Plasmodium vivax infections: A longitudinal study from Ethiopia.

The Journal of infection·2026

Related Experiment Video

Updated: May 3, 2026

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
10:02

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD

Published on: March 12, 2020

16.7K

Designer psychostimulants: pharmacology and differences.

Leslie Iversen1, Michael White2, Ric Treble3

  • 1Department of Pharmacology, University of Oxford, Mansfield Road, OX1 3QT, UK.

Neuropharmacology
|January 25, 2014
PubMed
Summary
This summary is machine-generated.

Novel psychoactive drugs, particularly designer psychostimulants, mimic amphetamines and cocaine. These substances activate brain monoamine systems, with some showing potential for dependence liability.

Keywords:
AmphetamineCathinonesCocaineEcstasyMephedroneMonoamine transporters

More Related Videos

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices
07:56

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices

Published on: August 11, 2021

2.6K
Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
09:44

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

772

Related Experiment Videos

Last Updated: May 3, 2026

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
10:02

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD

Published on: March 12, 2020

16.7K
A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices
07:56

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices

Published on: August 11, 2021

2.6K
Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
09:44

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

772

Area of Science:

  • Neuroscience
  • Pharmacology
  • Medicinal Chemistry

Background:

  • Over 200 novel psychoactive drugs (NPS) reported in Europe, with rapid emergence of new compounds.
  • Many NPS are designer psychostimulants aiming to replicate effects of amphetamines, cocaine, or MDMA.
  • Emerging NPS include substituted cathinones, aminoindanes, aminotetralins, piperazines, amphetamine analogues, and pipradrol derivatives.

Purpose of the Study:

  • To review scientific studies on the pharmacology of novel psychostimulants published between 2011-2013.
  • To analyze the mechanisms of action and potential for abuse of emerging designer drugs.

Main Methods:

  • Review of scientific literature on novel psychostimulants.
  • Analysis of drug discrimination tests in rats.
  • Evaluation of conditioned place preference and self-administration behavior.

Main Results:

  • Novel psychostimulants activate brain monoamine systems (dopamine and/or serotonin) with varying preferences.
  • Dopamine-preferring stimulants include naphyrone, MDPV, and benzylpiperazine (amphetamine-like).
  • Serotonin-preferring stimulants include mephedrone, methylone, substituted cathinones, aminoindanes, aminotetralins, and piperazines (MDMA/cocaine-like).

Conclusions:

  • Novel psychostimulants exhibit diverse pharmacological profiles, primarily targeting monoamine neurotransmission.
  • Drugs like mephedrone demonstrate abuse potential, indicated by substitution in drug discrimination and induction of reward-related behaviors.
  • Understanding the neuropharmacology of these substances is crucial for public health and harm reduction strategies.